Evoke Pharma Inc (EVOK)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David A. Gonyer
Employees:
6
420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA 92075
858-345-1494

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops EVK-001 for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in Solana Beach, CA.

Data derived from most recent annual or quarterly report
Market Cap 100.4 Million Shares Outstanding32.918 Million Avg 30-day Volume 2.637 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.15
Price to Revenue10.2043 Debt to Equity2.5853 EBITDA-7.612 Million
Price to Book Value10.2677 Operating Margin-391.1733 Enterprise Value17.157 Million
Current Ratio6.653 EPS Growth0.509 Quick Ratio5.985
1 Yr BETA 4.4309 52-week High/Low 18.96 / 2.03 Profit Margin-416.5455
Operating Cash Flow Growth-37.1503 Altman Z-Score-16.8666 Free Cash Flow to Firm -9.936 Million
View SEC Filings from EVOK instead.

View recent insider trading info

Funds Holding EVOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EVOK BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-08:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-23:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-20:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-04-26:
    Item 8.01: Other Events
  • 8-K: filed on 2022-03-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-24:
    Item 8.01: Other Events
  • 8-K: filed on 2022-02-17:
    Item 8.01: Other Events
  • 8-K: filed on 2022-01-04:
    Item 8.01: Other Events
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GARNER CAM L

    • Director
    67,500 2022-04-27 1

    WIDDER KENNETH J

    • Director
    56,000 2022-04-27 1

    REED VICKIE S

    • Director
    58,000 2022-04-27 1

    HILL MALCOLM R

    • Director
    57,750 2022-04-27 1

    BRADY TODD C

    • Director
    57,750 2022-04-27 1

    GONYER DAVID A PRESIDENT AND CEO

    • Officer
    • Director
    175,000 2022-02-02 1

    D'ONOFRIO MATTHEW J EXEC VP, CHIEF BUS. OFFICER

    • Officer
    100,000 2022-02-02 1

    CARLSON MARILYN R. CHIEF MEDICAL OFFICER

    • Officer
    100,000 2022-02-02 1

    RHOADS ANN D

    • Director
    61,750 2021-05-05 0

    LVP GP III, LLC

    LATTERELL PATRICK F

    LVP III ASSOCIATES, L.P.

    LVP III PARTNERS LP

    LVP LIFE SCIENCE VENTURES III L.P.

    LVPMC, LLC

    • 10% Owner
    2,088,579 2018-08-20 0

    GLENN SCOTT L

    • Director
    0 2018-04-26 0

    DP VII ASSOCIATES LP

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    No longer subject to file 2016-05-26 0

    DOMAIN PARTERS VII L P

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    No longer subject to file 2016-05-26 0

    DP VII ASSOCIATES LP

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    SCHOEMAKER KATHLEEN K

    HALAK BRIAN K

    • 10% Owner
    17,947 2015-08-18 0

    DOMAIN PARTERS VII L P

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    SCHOEMAKER KATHLEEN K

    HALAK BRIAN K

    • 10% Owner
    1,052,328 2015-08-18 0

    SHAH NIMESH

    • 10% Owner
    5,250 2015-01-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    EVOKE PHARMA INC EVOK 2022-06-29 22:15:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 21:45:05 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 21:15:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 20:45:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 20:15:04 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 19:45:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 19:15:04 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 18:45:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 18:15:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 17:45:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 17:15:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 16:45:03 UTC -188.2916 189.8616 50000
    EVOKE PHARMA INC EVOK 2022-06-29 16:15:03 UTC -188.2916 189.8616 15000
    EVOKE PHARMA INC EVOK 2022-06-29 15:45:03 UTC -188.2916 189.8616 15000
    EVOKE PHARMA INC EVOK 2022-06-29 15:15:03 UTC -188.2916 189.8616 15000
    EVOKE PHARMA INC EVOK 2022-06-29 14:45:03 UTC -188.2916 189.8616 20000
    EVOKE PHARMA INC EVOK 2022-06-29 14:15:03 UTC -188.2916 189.8616 20000
    EVOKE PHARMA INC EVOK 2022-06-29 13:45:03 UTC -276.5589 278.1289 20000
    EVOKE PHARMA INC EVOK 2022-06-29 13:15:03 UTC -276.5589 278.1289 20000
    EVOKE PHARMA INC EVOK 2022-06-29 12:45:02 UTC -276.5589 278.1289 15000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund EVOK -2600.0 shares, $-1287.0 2022-03-31 N-PORT

    Elevate your investments